The Mayo Clinic, a prominent nonprofit medical center, has announced a strategic partnership with Silicon Valley startup Cerebras Systems to collaborate on the development of artificial intelligence (AI) models for the healthcare industry. This partnership aims to leverage Cerebras' advanced computing chips and systems to harness decades' worth of anonymized medical records and data held by the Mayo Clinic.
Mayo Clinic, known for its three major campuses in the US and additional global locations, plans to utilize Cerebras' technology to develop AI models with various capabilities. Some of these models are envisioned to process and generate text, such as summarizing essential information from lengthy medical records for new patients. Additionally, other models will focus on analyzing images for patterns that may not be easily discernible by human experts, as well as scrutinizing genome data. Notably, the AI models will not replace medical decision-making, which will continue to be the responsibility of healthcare professionals.
According to Matthew Callstrom, Mayo's medical director for strategy and chair of its radiology department, AI is seen as an augmentation tool to assist healthcare professionals in making informed decisions for each patient.
The outcomes of Mayo Clinic's collaboration with Cerebras are expected to be integrated into the Mayo Clinic Platform, a data network also utilized by healthcare systems such as Mercy in the US, University Health Network in Canada, and others globally. The Mayo Clinic Platform is designed to facilitate data-sharing and collaboration among healthcare institutions.
While specific details about the financial aspects of the partnership were not disclosed, Cerebras Systems CEO Andrew Feldman mentioned that it involves a "multi-million-dollar" agreement spanning several years. Cerebras will contribute both hardware and software development services to Mayo Clinic as part of the collaboration. The Mayo Clinic plans to reveal more details about this initiative during an address at JPMorgan Chase's healthcare conference in San Francisco.
